Regentis Biomaterials Ltd RGNT
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Regentis Biomaterials Reports Strong Surgeon Interest in GelrinC(R) at 8th ICRS Summit in Portugal
-
Regentis Biomaterials to Present at the 2026 ThinkEquity Conference on October 15 in New York City
-
Regentis Biomaterials Reports First Half 2026 Financial Results and Provides Corporate Update
-
Regentis Receives Japanese Patent allowance, Strengthening its Global GelrinC Intellectual Property Portfolio with New Proprietary Manufacturing Technology
Trading Information
- Previous Close Price
- $1.55
- Day Range
- $1.51–1.60
- 52-Week Range
- $0.00–15.50
- Bid/Ask
- $1.52 / $1.59
- Shares Outstanding
- 7.02M
- Market Cap
- $10.61M
- Volume/Avg
- 5,118 / 72,192
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Regentis Biomaterials Ltd is a regenerative medicine company dedicated to developing tissue repair solutions that restore health and enhance the quality of life of patients. It is focused on orthopedic treatments using its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue). Gelrin is a hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen (a biologically inactivated protein that normally has a role in blood clotting). Its product is GelrinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries to articular knee cartilage.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- —
- Total Number of Employees
- 7
- Website
- https://www.regentis.co.il
Valuation
|
Metric
|
RGNT
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 1.49 |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
RGNT
|
|---|---|
Quick Ratio | 5.42 |
Current Ratio | 5.62 |
Interest Coverage | −40.20 |
Quick Ratio
RGNT
Profitability
|
Metric
|
RGNT
|
|---|---|
Return on Assets (Normalized) | −223.93% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
RGNT
Medical Instruments & Supplies Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| LOCK|<gKWRhK | LOCK|@r | $151B | |||
| Becton Dickinson & Co
BDX
| LOCK|hB | LOCK|cskgp | $53B | |||
| ResMed Inc
RMD
| LOCK|YVWrhzt | LOCK|Kvj?Y | $34B | |||
| Medline Inc Ordinary Shares - Class A
MDLN
| LOCK|#jRP$@ | LOCK|D^&Y# | $32B | |||
| Alcon Inc
ALC
| LOCK|RXp<!V^ | LOCK|#h&< | $32B | |||
| West Pharmaceutical Services Inc
WST
| LOCK|Qjk@pj?% | LOCK|tm | $27B | |||
| Solventum Corp
SOLV
| LOCK|M%%Qk!d | LOCK|S&H | $15B | |||
| Baxter International Inc
BAX
| LOCK|SPk | LOCK|!$c@ | $13B | |||
| Repligen Corp
RGEN
| LOCK|tvtWM>F^ | LOCK|ZK!^ | $12B | |||
| The Cooper Companies Inc
COO
| LOCK|YGB%Ky | LOCK|F^fP | $11B |
United States